Evolent Health (EVH)Durable Capital Partners LP opened a new position $72.3M
Durable Capital Partners LP opened a new position in Evolent Health, per its Q2 2025 13F.
- 6.42M
- Shares reported
- 0.55%
- Disclosed portfolio weight
- $72.3M
- Reported value
- Holdings as of
- Jun 30, 2025
- Filed
- Aug 14, 2025
The story around this disclosure
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.
What came next
- Nov 6, 2025Company filing · Form 8-K · Results, Executive changeChanged a top executive or board member, and reported its results“On November 6, 2025, the Company announced a restructuring of leadership roles and transitions of its leadership team. Chief Financial Officer Transition On November 6, 2025, the Board of Directors (the “Board”) of the Company appointed Mario Ramos, 54, as the Company’s Chief Financial Officer (principal financial officer), effective January 1, 2026 (the “Effective Date”).”
- Dec 1, 2025Company filing · Form 8-K · Executive change, Reg FDChanged a top executive or board member, and shared information with investors“On December 1, 2025, Ms. Cheryl Scott retired from the Board of Directors (the “Board”) of Evolent Health, Inc. (the “Company”). Ms. Scott’s decision to retire was not the result of any disagreement between the Company and Ms. Scott on any matter relating to the Company’s operations, policies or practices.”
How to read SEC Form 13F-HR
Form 13F is the quarterly report in which investment managers that oversee $100 million or more list the US-listed stocks and some other securities they held on the last day of the quarter.
Full guide: What is an SEC Form 13F?
What else is on file for Evolent Health
OQRO holds no insider, Congress, fund or contract record for Evolent Health dated in the last 90 days.
These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its EVH page.
How this filing works
Other disclosures at Evolent Health
- SEC Form 13F-HRFeb 13, 2026
- SEC Form 13F-HRFeb 13, 2026
- SEC Form 13F-HRNov 14, 2025
- SEC Form 13F-HRNov 14, 2025
- SEC Form 13F-HRNov 14, 2025
- SEC Form 13F-HRAug 14, 2025
Everything OQRO holds on this company is on its EVH page.
This is one filing. OQRO holds the rest
Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.
OQRO Pro is a paid subscription. You see the price before you pay
OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data